BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 21965653)

  • 1. E3 ligases determine ubiquitination site and conjugate type by enforcing specificity on E2 enzymes.
    David Y; Ternette N; Edelmann MJ; Ziv T; Gayer B; Sertchook R; Dadon Y; Kessler BM; Navon A
    J Biol Chem; 2011 Dec; 286(51):44104-44115. PubMed ID: 21965653
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Auto-ubiquitination of Mdm2 enhances its substrate ubiquitin ligase activity.
    Ranaweera RS; Yang X
    J Biol Chem; 2013 Jun; 288(26):18939-46. PubMed ID: 23671280
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Smad ubiquitylation regulatory factor 1/2 (Smurf1/2) promotes p53 degradation by stabilizing the E3 ligase MDM2.
    Nie J; Xie P; Liu L; Xing G; Chang Z; Yin Y; Tian C; He F; Zhang L
    J Biol Chem; 2010 Jul; 285(30):22818-30. PubMed ID: 20484049
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulation of p53 by the ubiquitin-conjugating enzymes UbcH5B/C in vivo.
    Saville MK; Sparks A; Xirodimas DP; Wardrop J; Stevenson LF; Bourdon JC; Woods YL; Lane DP
    J Biol Chem; 2004 Oct; 279(40):42169-81. PubMed ID: 15280377
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phosphomimetic mutation of the N-terminal lid of MDM2 enhances the polyubiquitination of p53 through stimulation of E2-ubiquitin thioester hydrolysis.
    Fraser JA; Worrall EG; Lin Y; Landre V; Pettersson S; Blackburn E; Walkinshaw M; Muller P; Vojtesek B; Ball K; Hupp TR
    J Mol Biol; 2015 Apr; 427(8):1728-47. PubMed ID: 25543083
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Topors functions as an E3 ubiquitin ligase with specific E2 enzymes and ubiquitinates p53.
    Rajendra R; Malegaonkar D; Pungaliya P; Marshall H; Rasheed Z; Brownell J; Liu LF; Lutzker S; Saleem A; Rubin EH
    J Biol Chem; 2004 Aug; 279(35):36440-4. PubMed ID: 15247280
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A site-directed mutagenesis study of the MdmX RING domain.
    Egorova O; Mis M; Sheng Y
    Biochem Biophys Res Commun; 2014 May; 447(4):696-701. PubMed ID: 24755078
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interplay between MDM2, MDMX, Pirh2 and COP1: the negative regulators of p53.
    Wang L; He G; Zhang P; Wang X; Jiang M; Yu L
    Mol Biol Rep; 2011 Jan; 38(1):229-36. PubMed ID: 20333547
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MDMX Recruits UbcH5c to Facilitate MDM2 E3 Ligase Activity and Subsequent p53 Degradation
    Yang J; Jin A; Han J; Chen X; Zheng J; Zhang Y
    Cancer Res; 2021 Feb; 81(4):898-909. PubMed ID: 33277368
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MdmX protein is essential for Mdm2 protein-mediated p53 polyubiquitination.
    Wang X; Wang J; Jiang X
    J Biol Chem; 2011 Jul; 286(27):23725-34. PubMed ID: 21572037
    [TBL] [Abstract][Full Text] [Related]  

  • 11. p53 regulation: teamwork between RING domains of Mdm2 and MdmX.
    Wang X
    Cell Cycle; 2011 Dec; 10(24):4225-9. PubMed ID: 22134240
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MdmX is a RING finger ubiquitin ligase capable of synergistically enhancing Mdm2 ubiquitination.
    Badciong JC; Haas AL
    J Biol Chem; 2002 Dec; 277(51):49668-75. PubMed ID: 12393902
    [TBL] [Abstract][Full Text] [Related]  

  • 13. E3 ubiquitin-protein ligase TRIM21-mediated lysine capture by UBE2E1 reveals substrate-targeting mode of a ubiquitin-conjugating E2.
    Anandapadamanaban M; Kyriakidis NC; Csizmók V; Wallenhammar A; Espinosa AC; Ahlner A; Round AR; Trewhella J; Moche M; Wahren-Herlenius M; Sunnerhagen M
    J Biol Chem; 2019 Jul; 294(30):11404-11419. PubMed ID: 31160341
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structure of a RING E3 ligase and ubiquitin-loaded E2 primed for catalysis.
    Plechanovová A; Jaffray EG; Tatham MH; Naismith JH; Hay RT
    Nature; 2012 Sep; 489(7414):115-20. PubMed ID: 22842904
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular basis for lysine specificity in the yeast ubiquitin-conjugating enzyme Cdc34.
    Sadowski M; Suryadinata R; Lai X; Heierhorst J; Sarcevic B
    Mol Cell Biol; 2010 May; 30(10):2316-29. PubMed ID: 20194622
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Critical contribution of the MDM2 acidic domain to p53 ubiquitination.
    Kawai H; Wiederschain D; Yuan ZM
    Mol Cell Biol; 2003 Jul; 23(14):4939-47. PubMed ID: 12832479
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Functional analysis and consequences of Mdm2 E3 ligase inhibition in human tumor cells.
    Wade M; Li YC; Matani AS; Braun SM; Milanesi F; Rodewald LW; Wahl GM
    Oncogene; 2012 Nov; 31(45):4789-97. PubMed ID: 22266850
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dynamic interactions of proteins in complex networks: identifying the complete set of interacting E2s for functional investigation of E3-dependent protein ubiquitination.
    Christensen DE; Klevit RE
    FEBS J; 2009 Oct; 276(19):5381-9. PubMed ID: 19712108
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structural analysis of MDM2 RING separates degradation from regulation of p53 transcription activity.
    Nomura K; Klejnot M; Kowalczyk D; Hock AK; Sibbet GJ; Vousden KH; Huang DT
    Nat Struct Mol Biol; 2017 Jul; 24(7):578-587. PubMed ID: 28553961
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Determinants of E2-ubiquitin conjugate recognition by RBR E3 ligases.
    Martino L; Brown NR; Masino L; Esposito D; Rittinger K
    Sci Rep; 2018 Jan; 8(1):68. PubMed ID: 29311602
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.